Prostate cancer decisions — 2026

The Veteran's prostate cancer and erectile dysfunction are granted service connection with an effective date of October 3, 2019. The Veteran also receives SMC based on loss of use of a creative organ starting from the same date.

The Board has granted service connection for prostate cancer and erectile dysfunction as due to herbicide exposure, specifically Agent Orange. The Veteran's prostate cancer is presumed based on his military service in Thailand during the Vietnam era.

The Veteran's claims for service connection for prostate cancer, hypertension, and thyroid disability (claimed as hypothyroidism) have been granted. The claim for thyroid disability remains pending due to insufficient evidence.

The Veteran's prostate cancer and residuals are granted as service connected due to exposure to ionizing radiation during service. The skin disorder claim is remanded for further examination.

The Veteran's prostate cancer was granted service connection effective April 22, 2009, based on new evidence from the PACT Act and the CHECO Report. The initial rating assigned is 60 percent.

The Veteran's prostate cancer is granted as service-connected due to exposure to herbicide agents in Korea, meeting the presumptive criteria.

The Board has granted service connection for allergic rhinitis due to in-service exposure, but remanded the issue of service connection for prostate cancer due to an incomplete record.

The Veteran's claims for service connection for obstructive sleep apnea, prostate cancer, and hypothyroidism are being remanded due to the need for additional medical opinions and treatment records.

The Board has determined that new evidence submitted by the Veteran relates to his service connection claims for a back disability, prostate cancer, and kidney disease. As such, these claims are being remanded for further review.

The Board has remanded the case due to insufficient medical opinions regarding the cause of the Veteran's death, specifically concerning his bladder cancer and other cancers allegedly caused by exposure to contaminated water at Camp Lejeune.

The Board has denied the Veteran's claims for service connection for prostate cancer and squamous cell carcinoma, finding that there is not sufficient evidence to establish a nexus between these conditions and his military service.

The Board has remanded the claims for increased ratings for PTSD and prostate cancer, as well as entitlement to a TDIU. The appellant is seeking higher ratings for these conditions on the basis of substitution or for accrued benefits purposes.

The Veteran's prostate cancer is granted as service connection due to presumed exposure at Camp Lejeune.,Bone and lymph node cancers are denied as service connection, with no presumptive basis established.

The Veteran's sleep apnea, prostate cancer, and non-Hodgkins lymphoma have been granted service connection on a direct basis.,Reasonable doubt has been resolved in favor of the Veteran for all three conditions.

The Veteran's prostate cancer is remanded for further development, including a new VA medical opinion and research into his exposure to fuel during service.

The Veteran's service-connected disabilities have prevented him from obtaining and maintaining substantial gainful employment since September 16, 2004. The Board has granted TDIU based on the severity of his service-connected conditions.

The Board denied the Veteran's appeals for service connection and increased rating for prostate cancer with lower urinary tract symptoms, as well as ED. The effective date of service connection was set at August 10, 2022.

The Board denied service connection for prostate cancer, hypertension, and bilateral hearing loss as there was no evidence of onset or manifestation during service or within one year post-service. The Veteran's lay statements were not considered sufficient to establish a nexus between the conditions and service.

The appeal concerning entitlement to compensation under 38 U.S.C. § 1151 for prostate cancer is dismissed due to the appellant's death.

The Board has decided to remand the case due to a duty-to-assist error and inadequate medical opinions. The Veteran's prostate cancer is related to service, but more evidence is needed to determine its exact cause.